Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium

Published:2009-09-01 Issue:9 Volume:119 Page:2702-2713
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Lee Daekee,Yu Ming,Lee Eunjung,Kim Hyunok,Yang Yanan,Kim Kyoungmi,Pannicia Christina,Kurie Jonathan M.,Threadgill David W.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference44 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors

2. Overview of the Current Status of Human Epidermal Growth Factor Receptor Inhibitors in Lung Cancer

3. Palliative management of rectal cancer: the roles of chemotherapy and radiation therapy

4. Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal Adenocarcinoma

5. Responses of Human Colorectal Tumor Cells to Treatment with the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody ICR62 Used Alone and in Combination with the EGFR Tyrosine Kinase Inhibitor Gefitinib

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance;Cancer Letters;2024-09

2. Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice;Journal of Investigative Dermatology;2024-07

3. Dynamics and plasticity of stem cells in the regenerating human colonic epithelium;2023-12-18

4. Inhibiting HER3 Hyperphosphorylation in HER2‐Overexpressing Breast Cancer through Multimodal Therapy with Branched Gold Nanoshells;Small;2023-08-26

5. Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor;Pharmacological Reviews;2023-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3